Terzuoli et al. (2016) reported that induced ubiquitination results in the degradation of EGFR in lysosomes both in vivo and in vitro, a molecular mechanism that can be utilized to evaluate the antiproliferative impact of HTyr therapy in CRC. Here, EGFR is linked to colorectal carcinoma.